BACE1 and Alzheimer disease: Thus, these identified ceRNA modules comprising NEAT1, SOX21-AS1, BACE1-AS, miR-107, targets of miR-107, and BACE1 can be further assessed as potential ceRNA modules for ceRNA-based therapeutic purposes in AD.